BriaCell Therapeutics Corp. (BCTX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Is it worth investing in BriaCell Therapeutics (BCTX), given the dependence on funding and the outcome of immunotherapy trials? The GURU.Markets platform features this chart, where the valuation of future earnings per share growth has reached 0.00. The asset is burdened by a lack of revenue and the risk of losing ground to new drugs, while cellular product manufacturing lines are fully utilized for current research.

BCTX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep BriaCell Therapeutics Corp 04.07.2022 - 15.11.2026

BCTX (BriaCell): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:

Rega saham BriaCell Therapeutics Corp.|BCTX - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Nilai pasar BriaCell Corp|BCTX - Nilai Bisnis

- rincian nilai buku perusahaan:

Nilai Buku saben Saham BriaCell|BCTX - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku briacell.com|BCTX - Nilai Agregat Aset

- statistik kawajiban utang lan likuiditas:

Total Utang marang Modal BriaCell Therapeutics|BCTX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal BriaCell Therapeutics Corp.|BCTX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku BriaCell Therapeutics Corp|BCTX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan BriaCell|Likuiditas cepet briacell.com

- informasi bathi lan kelipatan valuasi:

BCTX - Bathi resik perusahaan|Bathi sing dikarepake BriaCell Therapeutics|BCTX - Rasio rega marang bathi|Prakiraan rega marang bathi BriaCell|BCTX - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BriaCell|BCTX - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) BriaCell|BCTX - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan briacell.com|BCTX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BriaCell Therapeutics

- statistik dodolan lan pendapatan perusahaan:

BCTX - Pendapatan dodolan perusahaan|Prakiraan volume dodolan BriaCell Corp|BCTX - Multiplikator P/S|Rasio rega marang prakiraan pendapatan BriaCell Therapeutics|BCTX - Wutah dodolan taun lumaku

Analisis dhasar perusahaan:briacell.com, BCTX

This indicator measures the expected earnings per share (EPS) growth, reflecting the analysts' consensus forecast for the business's future profitability. For BriaCell Therapeutics (BCTX), this growth depends directly on the commercialization of Bria-IMT patent protocols and the scaling of the cell therapy system. By analyzing the forward-looking EPS growth forecast, an investor can assess the asset's fundamental stability and the risk of overpaying for future success.

Analisis perusahaan pesaing

MRUS (Merus NV) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep immutep.com IMMP|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Anixa Biosciences Inc (ANIX)|Atossa Therapeutics, Inc. - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CNTX (Context Therapeutics)|MRSN - Prakiraan wutah bathi saben saham kanggo taun ngarep|EPIX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep QTI (QT Imaging Holdings, Inc.)